156 related articles for article (PubMed ID: 37340110)
1. Gastric Cancer Surgery in the US: a Contemporary Trend Analysis of Lymphadenectomy and the Impact of Minimally Invasive Approaches.
Maegawa FB; Patel AD; Serrot FJ; Patel SG; Stetler JL; Patel DC; Ghaderi I; Hsu CH; Ashouri Y; Sarmiento JM; Konstantinidis IT; Lin E
J Gastrointest Surg; 2023 Sep; 27(9):1825-1836. PubMed ID: 37340110
[TBL] [Abstract][Full Text] [Related]
2. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
3. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
4. Lymphadenectomy in patients with gastric cancer. A critical review.
Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.
Hyung WJ; Yang HK; Park YK; Lee HJ; An JY; Kim W; Kim HI; Kim HH; Ryu SW; Hur H; Kim MC; Kong SH; Cho GS; Kim JJ; Park DJ; Ryu KW; Kim YW; Kim JW; Lee JH; Han SU;
J Clin Oncol; 2020 Oct; 38(28):3304-3313. PubMed ID: 32816629
[TBL] [Abstract][Full Text] [Related]
6. Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy.
Lee J; Kim YM; Woo Y; Obama K; Noh SH; Hyung WJ
Surg Endosc; 2015 Nov; 29(11):3251-60. PubMed ID: 25631106
[TBL] [Abstract][Full Text] [Related]
7. Robotic versus laparoscopic gastrectomy for adenocarcinoma in the US: a propensity score-matching analysis of 11,173 patients on oncological adequacy.
Maegawa FB; Patel AD; Patel SG; Stetler JL; Patel DC; Ashouri Y; Sarmiento JM; Konstantinidis IT; Lin E
Surg Endosc; 2023 Dec; 37(12):9643-9650. PubMed ID: 37943334
[TBL] [Abstract][Full Text] [Related]
8. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base.
Datta J; Lewis RS; Mamtani R; Stripp D; Kelz RR; Drebin JA; Fraker DL; Karakousis GC; Roses RE
Cancer; 2014 Sep; 120(18):2855-65. PubMed ID: 24854027
[TBL] [Abstract][Full Text] [Related]
9. Aggressive D2 lymphadenectomy is required for accurate pathologic staging of gastric adenocarcinoma.
Smith BR; Stabile BE
Am Surg; 2006 Oct; 72(10):849-52. PubMed ID: 17058719
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
11. [Long-term efficacy of robotic radical total gastrectomy for gastric cancer and analysis of prognostic factors].
Xie SH; Shi Y; Long D; Chen J; Zhao YL; Qian F; Hao YX; Tang B; Li PA; Yu PW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):357-363. PubMed ID: 32306603
[No Abstract] [Full Text] [Related]
12. Totally laparoscopic gastric resection with extended lymphadenectomy for gastric adenocarcinoma.
Guzman EA; Pigazzi A; Lee B; Soriano PA; Nelson RA; Benjamin Paz I; Trisal V; Kim J; Ellenhorn JD
Ann Surg Oncol; 2009 Aug; 16(8):2218-23. PubMed ID: 19444523
[TBL] [Abstract][Full Text] [Related]
13. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
15. Lymph Node Evaluation after Neoadjuvant Chemotherapy for Patients with Gastric Cancer.
Shannon AB; Straker RJ; Keele L; Fraker DL; Roses RE; Miura JT; Karakousis GC
Ann Surg Oncol; 2022 Feb; 29(2):1242-1253. PubMed ID: 34601642
[TBL] [Abstract][Full Text] [Related]
16. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center: the Cremona experience.
Ghidini M; Donida BM; Totaro L; Ratti M; Pizzo C; Benzoni I; Lomiento D; Aldighieri F; Toppo L; Ranieri V; Senti C; Tanzi G; Martinotti M; Passalacqua R; Rovatti M; Tomasello G
Clin Transl Oncol; 2020 Jul; 22(7):1004-1012. PubMed ID: 31599376
[TBL] [Abstract][Full Text] [Related]
18. Impact of the anatomical location and the number of metastatic lymph nodes on gastric cancer patient´s survival.
Duchon R; Bernadic M; Pindak D
Bratisl Lek Listy; 2020; 121(4):253-258. PubMed ID: 32356438
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing quality of lymphadenectomy in minimally invasive esophagectomy: a US-based analysis.
Odetoyinbo K; Bachman K; Worrell S; Gray K; Linden P; Towe C
Dis Esophagus; 2022 Oct; 35(10):. PubMed ID: 35039833
[TBL] [Abstract][Full Text] [Related]
20. D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival.
Wohnrath DR; Araujo RLC
Eur J Surg Oncol; 2019 Mar; 45(3):446-453. PubMed ID: 30392746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
